Creative Medical Technology Holdings, Inc.
CELZNasdaqCIK 1187953HealthcareFiscal year ends Dec 31
Reports and events: 215 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0121:00 ET | SCHEDULE 13D | Ownership report, active investor | 0001477932-26-005959 |
| 2026-09-2521:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001477932-26-005805 |
| 2026-08-3120:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001477932-26-005329 |
| 2026-08-0721:23 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001477932-26-004779 |
| 2026-07-1420:00 ET | DEF 14A | Proxy statementPeriod 2026-08-28 | 0001477932-26-004302 |
| 2026-07-0220:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001477932-26-004165 |
| 2026-06-2620:16 ET | S-1/A | Registration statement, amended | 0001477932-26-004044 |
| 2026-06-2520:06 ET | S-1 | Registration statement | 0001477932-26-004010 |
| 2026-05-0820:45 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001477932-26-002893 |
| 2026-04-2420:45 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001477932-26-002534 |
| 2026-03-2020:45 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001477932-26-001517 |
| 2025-12-3121:05 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001477932-25-009277 |
| 2025-12-1921:01 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001477932-25-009094 |
| 2025-11-1321:51 ET | DEF 14A | Proxy statementPeriod 2025-12-26 | 0001477932-25-008184 |
| 2025-11-1211:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001477932-25-008027 |
| 2025-11-0721:46 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001477932-25-007978 |
| 2025-10-3120:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001477932-25-007849 |
| 2025-10-3010:11 ET | DEF 14A | Proxy statementPeriod 2025-10-27 | 0001477932-25-007803 |
| 2025-08-0820:45 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001477932-25-005614 |
| 2025-05-0920:45 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001477932-25-003498 |
| 2025-05-0620:30 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001477932-25-003370 |
| 2025-04-2520:45 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001477932-25-002984 |
| 2025-04-1121:00 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001477932-25-002645 |
| 2025-04-0421:00 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001477932-25-002473 |
| 2025-03-1921:04 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001477932-25-001847 |
| 2025-03-1720:01 ET | DEF 14A | Proxy statementPeriod 2025-03-19 | 0001477932-25-001759 |
| 2025-03-1420:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001477932-25-001737 |
| 2025-03-1420:30 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001477932-25-001736 |
| 2025-03-0721:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001477932-25-001537 |
| 2024-12-2622:00 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001477932-24-008314 |
| 2024-11-0821:45 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001477932-24-006991 |
| 2024-11-0821:06 ET | S-1 | Registration statement | 0001477932-24-006986 |
| 2024-11-0421:01 ET | DEF 14A | Proxy statementPeriod 2024-12-19 | 0001477932-24-006871 |
| 2024-10-2320:23 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001477932-24-006644 |
| 2024-08-0920:45 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001477932-24-004635 |
| 2024-07-2520:10 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001477932-24-004377 |
| 2024-06-0520:05 ET | DEF 14A | Proxy statementPeriod 2024-07-19 | 0001477932-24-003511 |
| 2024-05-1720:02 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.08 Item not in the standard list; 9.01 Financial statements and exhibits | 0001477932-24-003116 |
| 2024-05-1020:45 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001477932-24-002695 |
| 2024-04-2920:45 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0001477932-24-002384 |
| 2024-03-2220:45 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001477932-24-001431 |
| 2023-12-2021:05 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001477932-23-009261 |
| 2023-11-1421:45 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001477932-23-008458 |
| 2023-11-0320:05 ET | DEF 14A | Proxy statementPeriod 2023-10-31 | 0001477932-23-008079 |
| 2023-08-1120:45 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001477932-23-005935 |
| 2023-06-2813:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-23-004849 |
| 2023-06-0920:15 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-23-004441 |
| 2023-05-1220:30 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001477932-23-003347 |
| 2023-05-0120:45 ET | 10-K/A | Annual report, amendedPeriod 2022-12-31 | 0001477932-23-003013 |
| 2023-03-3120:46 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001477932-23-002123 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:10 ET. Listed shows no prices and gives no investment advice.